A more in-depth analysis of specific myeloid populations revealed that moDCs (CD11b+CD11c+Ly6C+) and M-MDSCs (CD11b+CD11c−Ly6C+) both significantly expanded throughout tumor progression compared to healthy skin at day 0 (Figure 1B). The gene discussed is ITGAX; the disease is neoplasm.